Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials

Open Access

Peer-reviewed

Research Article

Lin Wang,

Affiliation Department of Cardiology, Chengdu Shang Jin Nan Fu Hospital, Chengdu, Sichuan Province, China
⨯
Moying Qu,

Affiliation Department of Cardiology, West China hospital of Sichuan University, Chengdu, Sichuan Province, China
⨯
Yao Chen,

Affiliation Department of Emergency, West China hospital of Sichuan University, Chengdu, Sichuan Province, China
⨯
Yaxiong Zhou,

Affiliation Department of Emergency, West China hospital of Sichuan University, Chengdu, Sichuan Province, China
⨯
Zhi Wan

* E-mail: 303680215@qq.com

Affiliation Department of Emergency, West China hospital of Sichuan University, Chengdu, Sichuan Province, China
⨯

Reader Comments (0)

Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Chronic obstructive pulmonary disease
Is the Subject Area "Chronic obstructive pulmonary disease" applicable to this article?

Thanks for your feedback.
Dyspnea
Is the Subject Area "Dyspnea" applicable to this article?

Thanks for your feedback.
Pulmonary hypertension
Is the Subject Area "Pulmonary hypertension" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.